SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ACADIA Pharmaceuticals Inc (ACAD) -- Ignore unavailable to you. Want to Upgrade?

To: mopgcw who wrote (538)8/13/2009 12:16:10 PM
From: rkrw  Respond to of 588
 
The market for the drug in PD really isn't very big, only a small subset and probably 70% downside risk from here if it misses. So i wouldn't worry too much about it when you can't predict the outcome with certainty.



To: mopgcw who wrote (538)9/1/2009 11:19:33 AM
From: keokalani'nui  Read Replies (2) | Respond to of 588
 
Nice move and ken too. And rkrw predicted stock would be -70% vulnerable to bad PD news. Stock now -68%. Impressive, you three.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News